Heparin and low molecular weight heparin for treatment of acute pulmonary embolism

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 4, 1999, Pages 216-221

  Raskob, Gary E ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; LUNG EMBOLISM; MALE; MORTALITY; PROGNOSIS; REVIEW; SURVIVAL RATE; THROMBOPHLEBITIS; TREATMENT OUTCOME;

ACUTE DISEASE; ANTICOAGULANTS; CLINICAL TRIALS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; PROGNOSIS; PULMONARY EMBOLISM; SURVIVAL RATE; THROMBOPHLEBITIS; TREATMENT OUTCOME;

EID: 0033162889     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199907000-00007     Document Type: Article

References (5)

1. Moser KM, Lemoine JR: Is embolie risk conditioned by localization of deep venous thrombosis? Ann Intern Med 1981, 94:439-444.
2. Prandoni P, Polistena P, Bernardi E, et al.: Upper-extremity deep vein thrombosis: risk factors, diagnosis and complications. Arch Intern Med 1997,157:57-62.
3. Claggett GP, Anderson FA, Geerts W, et al.: Prevention of venous thromboembolism. Chest 1998,114(suppl):531 -560.
4. Hull RD, Raskob GE, Ginsberg JS, Panju AA, Brill-Edwards P, Coates G, Pineo GF: A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med 1994,154:289-297.
5. Hull R, Hirsh J, Carter C, et al.: Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest 1985,88:819-828.